ARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell Therapies

Summary

ARPA-H's BoSS Program has funded three teams of companies, research agencies, and universities to develop alternatives to ultracold storage and controlled shipping for cell therapies and biologics. The initiative aims to improve patient access to these therapies by addressing cold chain challenges.